AMPK–SQSTM1 Feedback Loop Enables Dual Antioxidant Activation in Stress

Study Background and Research Question

Metabolic and oxidative stress are hallmarks of the tumor microenvironment, driving adaptive responses that enable cancer cell survival under nutrient depletion and accumulation of reactive oxygen species (ROS). Two key regulatory pathways—STK11/LKB1-AMPK and KEAP1-NFE2L2/NRF2—govern cellular energy homeostasis and antioxidant defense, respectively. However, the molecular crosstalk linking these pathways during metabolic stress had not been fully elucidated. The reference study (AUTOPHAGY 2024) set out to define how metabolic stress coordinates the activation of AMPK and NFE2L2/NRF2, and to clarify the roles of SQSTM1/p62 and TAK1 within this regulatory network, particularly in the context of co-occurring STK11 and KEAP1 mutations found in non-small cell lung cancer (NSCLC).

Key Innovation from the Reference Study

The study's major advance lies in the discovery of a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress. This circuit results in the simultaneous activation of both AMPK and NFE2L2/NRF2, thus synergizing antioxidant defenses in cancer cells. The feedback is built on reciprocal regulation: SQSTM1 is both a downstream effector and an upstream activator of AMPK, while AMPK activity is required for optimal expression and phosphorylation of SQSTM1. Importantly, this feedback loop mechanistically connects metabolic sensing to the orchestration of antioxidant responses, revealing why tumors with co-occurring STK11 and KEAP1 mutations may gain a selective advantage in nutrient-deprived microenvironments (reference study).

Methods and Experimental Design Insights

The authors combined genetic, biochemical, and cell biological approaches to dissect this regulatory network. Key experimental elements included:

• Use of NSCLC cell lines and mouse embryonic fibroblasts (MEFs) with engineered mutations in STK11 and KEAP1, modeling clinically relevant genetic backgrounds.
• Induction of metabolic stress via glucose deprivation and manipulation of lysosomal function (e.g., with bafilomycin A1, concanamycin A).
• Assessment of SQSTM1/p62 expression and phosphorylation using immunoblotting and immunoprecipitation.
• Pharmacological inhibition and gene knockdown of key pathway components (including TAK1/MAP3K7 and PP2A) to map causal relationships.
• Measurement of AMPK and NFE2L2/NRF2 activity using downstream target gene expression and functional antioxidant assays.
• Rescue and abrogation experiments with lactic acid to probe the role of lysosomal pH and proton gradients.

By systematically perturbing these nodes, the study delineated the order of events and feedback dependencies, allowing for a mechanistic model of the AMPK–SQSTM1–NFE2L2 axis under stress.

Core Findings and Why They Matter

Several key findings emerged from the investigation:

• Metabolic stress elevates SQSTM1/p62 expression and phosphorylation, which is required for the activation of both AMPK and NFE2L2/NRF2.
• SQSTM1-driven activation of NFE2L2/NRF2 arises from macroautophagy-dependent degradation of KEAP1, relieving inhibition of the antioxidant transcription factor.
• SQSTM1 also facilitates the formation of the AXIN–STK11–AMPK complex on the lysosomal membrane, boosting AMPK activation.
• AMPK activity is reciprocally required for stress-induced increases in SQSTM1, forming a double-positive feedback loop.
• PPP2/PP2A-dependent dephosphorylation of TFEB and TFE3—triggered by lysosomal deacidification—enhances SQSTM1 expression, linking nutrient status and lysosomal pH to the feedback loop.
• Phosphorylation of SQSTM1 at S24 and S226 by TAK1 (MAP3K7) is essential for dual activation of AMPK and NFE2L2, positioning TAK1 as an upstream modulator.
• Exogenous lactic acid can reverse metabolic stress-induced effects by restoring lysosomal protons, highlighting the importance of pH homeostasis.

These findings shed light on how cancer cells integrate signals from metabolic and oxidative stressors to sustain growth and survival. The elucidation of TAK1’s role in phosphorylating SQSTM1 connects this kinase to both autophagy and antioxidant defense, offering potential intervention points—such as selective TAK1 inhibitors—for future therapeutic strategy.

Comparison with Existing Internal Articles

The mechanistic insights from the reference study are further contextualized by related internal resources:

• The article "(5Z)-7-Oxozeaenol: Applied TAK1 Inhibition for Inflammation Models" details how (5Z)-7-Oxozeaenol enables precise dissection of TAK1-dependent signaling in cellular and animal inflammation models, aligning with the study’s focus on TAK1 as a regulatory node.
• "AMPK–SQSTM1 Feedback Drives Antioxidant Defense under Metabolic Stress" provides an accessible overview of the feedback loop and its implications for metabolic adaptation, reinforcing the reference study’s findings.
• For researchers interested in pharmacological intervention, "(5Z)-7-Oxozeaenol: TAK1 Inhibition and Metabolic Stress Insights" offers mechanistic and application-oriented perspectives on using TAK1 inhibitors to probe cellular stress responses.

Together, these resources bridge the gap between pathway discovery and experimental modeling, illustrating how insights from the reference study can inform both basic research and applied workflows.

Limitations and Transferability

While the feedback loop was characterized in NSCLC cells and MEFs, additional studies are needed to generalize these findings to other cancer types and physiological contexts. The reliance on engineered cell lines and pharmacological inhibitors, such as TAK1 inhibitors, introduces variables related to genetic background and compound specificity. Furthermore, the in vivo relevance of the AMPK–SQSTM1–NFE2L2 axis—particularly in the complex tumor microenvironment—remains to be validated in animal models. The study's focus on metabolic and oxidative stress may also limit direct transferability to settings where other forms of cellular stress predominate. Nonetheless, the identification of key phosphorylation sites and regulatory nodes provides a foundation for targeted investigation.

Protocol Parameters

• Modeling metabolic stress: Induce glucose deprivation in cell culture for 24–48 hours to trigger AMPK–SQSTM1–NFE2L2 pathway activation, as described in the reference study.
• SQSTM1 phosphorylation analysis: Use site-specific antibodies or mass spectrometry to detect S24 and S226 phosphorylation after stress induction or TAK1 modulation.
• TAK1 inhibition: Apply a TAK1 inhibitor such as (5Z)-7-Oxozeaenol at 500 nM for 17.5 hours to suppress TAK1 activity and assess downstream effects on SQSTM1 and pathway activation (product information).
• Lysosomal pH modulation: Supplement cultures with lactic acid to restore proton gradients and abrogate stress-induced feedback, per the reference study’s rescue assays.

Research Support Resources

To experimentally interrogate TAK1’s role in the AMPK–SQSTM1–NFE2L2 feedback loop or to model the impact of TAK1 inhibition on inflammation and metabolic adaptation, researchers may utilize (5Z)-7-Oxozeaenol (SKU B7443), a highly selective and potent TAK1 inhibitor. According to the product information, this compound irreversibly blocks TAK1 activity and is validated for use in both cellular and animal models of inflammation and metabolic stress. APExBIO provides detailed handling guidelines to support reproducible TAK1 inhibition workflows in research settings.